2007
DOI: 10.1186/1476-4598-6-17
|View full text |Cite
|
Sign up to set email alerts
|

Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer

Abstract: Background: Nidogens are highly conserved proteins of basement membranes. Two nidogen proteins, nidogen 1 and nidogen 2, are known in mammals.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
50
0

Year Published

2009
2009
2018
2018

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 67 publications
(53 citation statements)
references
References 23 publications
3
50
0
Order By: Relevance
“…On the other hand, loss of NID1 expression was frequently detected in human gastrointestinal tumor samples. 65 In this case it was proposed that the loss of NID1 could favor tumor invasion and metastasis by destabilizing the structure of BM and loosening the cell-BM interactions. It should be considered, however, that several reports described a pro-tumoral and pro-metastatic role for NID1.…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, loss of NID1 expression was frequently detected in human gastrointestinal tumor samples. 65 In this case it was proposed that the loss of NID1 could favor tumor invasion and metastasis by destabilizing the structure of BM and loosening the cell-BM interactions. It should be considered, however, that several reports described a pro-tumoral and pro-metastatic role for NID1.…”
Section: Discussionmentioning
confidence: 99%
“…Our results indicate that upregulation of TMPRSS2 can directly activate matriptase and degrade ECM components nidogen-1 and laminin b1, leading to prostate cancer progression. Nidogen-1 functions as a key component for basement membrane assembly by connecting laminin and collagen networks and integrating other ECM components (45), and decreased expression of nidogen-1 can weaken the strength of the basement membrane and the interaction between cancer cells and the ECM, leading to the promotion of cancer cell invasion and metastasis (46). Moreover, matriptase activation has been shown to alter the microenvironment by degradation of fibronectin and laminin (47), or by activation of pro-HGF, PAR-2, uPA, and MMP-1/-3 (10), all contributing to tumor growth and metastasis.…”
Section: Discussionmentioning
confidence: 99%
“…Involved in cell adhesion, migration and growth (Chiquet-Ehrismann and Chiquet, 2003), wound healing, and neovascularization (Hsia and Schwarzbauer, 2005;Trebaul et al, 2007) Ehlers-Danlos syndrome (Burch et al, 1997;Mao and Bristow, 2001) Fibrotic diseases, inflammation, tumorigenesis (Chiquet-Ehrismann and Chiquet, 2003) Thrombospondins (1-5) Involved in cell migration (Yabkowitz et al, 1993), platelet aggregation, inflammatory response, and wound healing (Adams and Lawler, 2004) Thrombospondin-5; pseudoachondroplasia and multiple epiphyseal dysplasia (Posey et al, 2008) Tumor progression (Lawler and Detmar, 2004;Kazerounian et al, 2008); atherosclerosis (Roth et al, 1998;Takahashi et al, 2008) Nidogen/entactin (nidogen 1 and nidogen 2) Involved in cell adhesion (Yi et al, 1998;Grimpe et al, 1999), wound healing (Sephel et al, 1996) and basement membrane stabilization (Ho et al, 2008) Osteoarthritis (Kruegel et al, 2008); cancer and tumor progression (Oivula et al, 1999;Ulazzi et al, 2007;…”
Section: Targeting Extracellular Matrix Molecules In Pharmacotherapymentioning
confidence: 99%